Variable | Number of carriers per subgroup | Prevalence carriage, per 100 children [95%CI] | Prevalence PCV7a carriage number; prevalence per 100 children [95%CI] | Prevalence PCV13–7b carriage number; prevalence per 100 children [95%CI] | Prevalence NVTc carriage number; prevalence per 100 children [95%CI] |
---|---|---|---|---|---|
Total | 431 | 48.1 [43.7–52.5] | 12; 1.3 [0.7–2.4] | 13;1.5 [0.8–2.6] | 412; 46.0 [41.5–50.5] |
Age in months | 431 included | Â | Â | Â | Â |
< 24 months | 84 | 60.4 [52.2–68.1] | 0; 0 [NA] | 1; 0.72 [0.09–5.4] | 84; 60.4 [52.2–68.1] |
24–35 months | 94 | 56.0 [48.1–63.6] | 2; 1.2 [0.28–5.0] | 1; 0.60 [0.08–4.4] | 91; 54.2 [46.0–62.1] |
36–47 months | 105 | 53.9 [46.0–61.5] | 4; 2.0 [0.61–6.7] | 6; 3.0 [1.5–6.1] | 98;50.3 [42.8–57.7] |
48–59 months | 89 | 42.8 [35.5–50.5] | 2; 0.96 [0.25–3.6] | 5; 2.4 [0.85–6.6] | 84; 40.4 [33.0–48.3] |
> = 60 months | 59 | 31.7 [24.6–39.8] | 4; 2.2 [0.83–5.5] | 0; 0 [NA] | 55; 29.6 [22.8–37.4] |
Vaccinated by type | 428 included |  |  |  |  |
PCV7 | 20 | 34.5 [22.9–48.3] | 1; 1.7 [0.22–12.1] | 0; 0 [NA] | 19; 32.8 [21.1–47.0] |
PCV7+13 | 52 | 30.1 [23.0–38.3] | 2; 1.2 [0.28–4.7] | 1; 0.58 [0.08–4.1] | 49; 28.3 [21.7–36.9] |
PCV13 | 354 | 54.5 [50.0–58.9] | 8; 1.2 [0.54–2.8] | 12; 1.9 [0.98–3.5] | 340; 52.3 [47.7–56.9] |
Unvaccinated | 2 | 40.0 [11.1–78.0] | 1; 20.0 [6.7–46.7] | 0; 0 [NA] | 1; 20.0 [6.7–46.7] |
Having used antimicrobials the past 3 months | 428 included |  |  |  |  |
Yes | 28 | 40.6 [30.9–51.1] | 0; 0 [NA] | 0; 0 [NA] | 28; 40.6 [30.9–51.1] |
No | 400 | 48.5 [44.0–53.1] | 12; 1.5 [0.80–2.6] | 12; 1.5 [0.78–2.7] | 382; 46.4 [41.7–51.1] |